Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » FDA Releases List of Evidence-Based PGx Variants

FDA Releases List of Evidence-Based PGx Variants

Feb 20, 2020
|
staff reporter

NEW YORK – The US Food and Drug Administration on Thursday unveiled a table of gene-drug associations for which it believes there is sufficient scientific evidence.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

A Start

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

Just Go 'Round the CDC

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

Student Visa Directive Rescinded

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

Cell Studies on Blood Features of Severe COVID-19 Cases, Infection-Related Phosphorylation Shifts, More

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

  2. BioMérieux BioFire Respiratory Panel With SARS-CoV-2 Target Nabs CE Mark

  3. FDA Grants EUA to KogeneBiotech, Trax Management, and Compass Laboratory Coronavirus Tests

  4. Dante Labs Software Nabs CE Mark for Interpretation of Whole-Genome Sequencing Data

  5. FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.